Back to News
Market Impact: 0.31

Here’s What Canaccord Thinks About Joby Aviation (JOBY)

Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsTransportation & LogisticsAutomotive & EVTechnology & Innovation
Here’s What Canaccord Thinks About Joby Aviation (JOBY)

Joby Aviation reported Q1 2026 revenue of $24 million, ahead of the $20.2 million forecast, and ended the quarter with $2.5 billion in cash. Management reaffirmed full-year 2026 revenue guidance of $105 million to $115 million and first-half cash usage guidance, suggesting a long runway before needing new capital. Canaccord cut its price target to $11.5 from $15.5 but kept a Hold rating after updating its model following the quarter.

Analysis

The key signal here is not the quarter itself but the de-risking of the capital structure. With a multibillion cash buffer and reaffirmed near-term burn, JOBY is entering the next 12-18 months with unusually low financing overhang for a pre-revenue hardware story; that should compress the probability-weighted dilution discount even if the equity remains fundamentally expensive. In other words, the stock may stop trading like a binary funding story and start trading more on certification milestones and order-book optionality.

The second-order effect is on competitive positioning within eVTOL: a company that can self-fund longer than peers can keep pace on testing, tooling, and regulatory engagement without conceding time-to-market. That matters because in this category, execution gaps compound quickly; each quarter of runway reduces the chance that a rival gets disproportionate attention from airlines, municipalities, or defense buyers simply by being first to show durability. The market may be underappreciating how much of the peer group is still effectively “fundraise-to-survive,” which makes JOBY relatively stronger even absent a re-rate in the near term.

The contrarian view is that the recent downgrade/target reset may be less about fundamentals deteriorating and more about valuation gravity: if the market had been pricing an aggressive commercialization curve, even good execution can still be insufficient to justify prior targets. The main reversal risk is not cash, but slippage in certification timing or any sign that unit economics require materially more iteration than currently modeled; that would hit the stock over months, not days. Near-term catalysts are more likely incremental than explosive, so upside is probably better harvested through staged exposure rather than a full cash equity bet.